Last update Oct. 15, 2016
Very Low Risk
We do not have alternatives for Loracarbef since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Loracarbef in other languages or writings:
Loracarbef belongs to this group or family:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 90 | % |
Molecular weight | 368 | daltons |
Protein Binding | 25 | % |
VD | 0.27 - 0.38 | l/Kg |
Tmax | 1.2 | hours |
T½ | 1 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Second-generation cephalosporin for oral administration with a chemical structure similar to cefaclor.
At latest update no published data on excretion into breast milk were found.
Cephalosporins for which data are available have shown to be excreted into milk in non-significant amount from a therapeutic point of view without reported complications in infants related to them.
Cephalosporins are widely used in the Pediatric practice with a high tolerance, even in the neonatal period, so it is very unlikely that such small amounts present in the milk may be a cause of problems to the infant.
Be aware of the possibility of false negative results of cultures in febrile infants whose mothers are taking antibiotics as well as the possibility of gastroenteritis (Ito 1993) by altering the intestinal flora.